PHA-40061 - Module Specification
School of Pharmacy and Bioengineering
Faculty of Medicine & Health Sciences

Programme/Approved Electives for 2023/24

Available as a Free Standing Elective

Co-requisites

None

Prerequisites

None

Barred Combinations

None

Description for 2023/24

This module will be relevant to healthcare professionals with an interest in the pharmaceutical management of cardiovascular disease. The aim of this module is to provide course participants with a comprehensive knowledge and understanding of the evidence base that supports the therapeutic interventions in the management of cardiovascular diseases in relation to patient care and medicines optimisation. The principal areas covered in this module are primary prevention of cardiovascular disease/risk assessment, dyslipidaemia, hypertension and heart failure.

The aim of this module is to provide course participants with a comprehensive knowledge and understanding of the evidence base that supports the therapeutic interventions in the management of cardiovascular diseases in relation to patient care and medicines optimisation.

Intended Learning Outcomes

Critically evaluate the management of patients, in line with the content on cardiovascular disease covered in the module, considering individual patient characteristics, expectations and health beliefs: 1
Demonstrate your ability to apply your knowledge and understanding of therapeutics, in line with the content on cardiovascular disease covered in the module, to optimise patient care in complex situations, considering the evidence-base and current professional practice: 1
Evaluate and reflect upon the application of your learning from content on cardiovascular disease covered in the module, and its impact on your current and future practice: 1

Study hours

100 hours, of which up to 20 hours maybe face-to-face contact. The remainder is by distance education media and technology, and learning in practice, plus completion of assessments.

School Rules

Applicants must be registered with the General Pharmaceutical Council, or equivalent for pharmacist working overseas, and be working full or part-time in a patient facing role. The module is also open to practising health professionals (in a patient facing role) who have studied to at least undergraduate degree level, or who have at least 5 years¿ experience of practising in their field. All applicants must also have the support of their workplace to access patient data where necessary for course learning activities and assessment. Applicants working in hospital pharmacy must normally be supported by a clinical co-ordinator in the work place who has been approved by School of Pharmacy/CPD4ALL.
We recommend that applicants should, normally, have worked in their practice setting for 6-12 months prior to commencing the Course so that they have gained some experience of working in practice.
Normally, only applicants with the minimum of a second class degree classification (or equivalent for applicants from outside the UK) in Pharmacy or other health related professional degree will be accepted onto the programme without interview. Exceptions will be considered on a case-by-case basis. The University reserves the right to interview prospective students and take up academic references. The final decision in any case rests with the University. Candidates are also admitted on the basis of perceived and potential competence to complete the programme.

Description of Module Assessment